 |
 Video: What is a Stock Split?
|
|
|
| United Therapeutics is a biotechnology company. Co. markets and sells four commercial therapies in the U.S. to treat pulmonary arterial hypertension: Tyvaso® (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Remodulin® (treprostinil) Injection (Remodulin); Orenitram® (treprostinil) Extended-Release Tablets; and Adcirca® (tadalafil) Tablets. Tyvaso has also been approved to treat pulmonary hypertension associated with interstitial lung disease. In the U.S., Co. also markets and sells an oncology product, Unituxin® (dinutuximab) Injection, which is approved for treatment of high-risk neuroblastoma, and the Remunity® Pump for Remodulin. According to our UTHR split history records, United Therapeutics has had 1 split. | |
|
United Therapeutics (UTHR) has 1 split in our UTHR split history database. The split for UTHR took place on September 23, 2009. This was a 2 for 1 split, meaning for each share of UTHR owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.
When a company such as United Therapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the UTHR split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into United Therapeutics shares, starting with a $10,000 purchase of UTHR, presented on a split-history-adjusted basis factoring in the complete UTHR split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$95.93 |
|
| End price/share: |
$237.93 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
148.02% |
|
| Average Annual Total Return: |
9.51% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$24,804.92 |
|
| Years: |
10.00 |
|
|
|
| Date |
Ratio |
| 09/23/2009 | 2 for 1 |
|
|
Free UTHR Email Alerts:
